Jagsonpal Pharmaceuticals Limited

NSE JAGSNPHARM.NS

Jagsonpal Pharmaceuticals Limited Free Cash Flow Yield on January 14, 2025: 2.55%

Jagsonpal Pharmaceuticals Limited Free Cash Flow Yield is 2.55% on January 14, 2025, a -47.11% change year over year. Free cash flow yield compares the return from free cash flow to the market cap; higher yield suggests attractive investment.
  • Jagsonpal Pharmaceuticals Limited 52-week high Free Cash Flow Yield is 6.53% on March 26, 2024, which is 156.04% above the current Free Cash Flow Yield.
  • Jagsonpal Pharmaceuticals Limited 52-week low Free Cash Flow Yield is 0.86% on January 03, 2025, which is -66.12% below the current Free Cash Flow Yield.
  • Jagsonpal Pharmaceuticals Limited average Free Cash Flow Yield for the last 52 weeks is 3.75%.
Key data
Date Free Cash Flow Yield Market Value Added (MVA) Price to Book Ratio (P/B) Price to Earnings Ratio (P/E)
Market news
Loading...
NSE: JAGSNPHARM.NS

Jagsonpal Pharmaceuticals Limited

CEO Mr. Manish Gupta
IPO Date July 1, 2002
Location India
Headquarters T-210 J, Shahpur Jat
Employees 1,025
Sector Health Care
Industries
Description

Jagsonpal Pharmaceuticals Limited develops and manufactures bulk drugs and pharmaceutical formulations in the areas of women health, pain and analgesics, and general medicine. It offers general medicines, such as allergy management, immunity and cell protection, gut and mind management, anti-infectives, and dentist and ENT range products; and women's healthcare products, including pregnancy care, and dysfunctional uterine bleeding complications and management products. The company also provides pain and analgesics products in the areas of pain management, and bone and joint care. It offers drugs in the form of tablets, capsules, and syrups. The company was founded in 1964 and is based in New Delhi, India. Jagsonpal Pharmaceuticals Limited is a subsidiary of Aresko Progressive Private Limited.

Similar companies

KOPRAN.NS

Kopran Limited

USD 2.30

4.06%

KABRAEXTRU.NS

Kabra Extrusiontechnik Limited

USD 5.49

2.46%

RPGLIFE.NS

RPG Life Sciences Limited

USD 23.77

2.82%

INDSWFTLAB.NS

Ind-Swift Laboratories Limited

USD 1.16

-0.19%

GUFICBIO.NS

Gufic Biosciences Limited

USD 5.42

-1.33%

StockViz Staff

January 15, 2025

Any question? Send us an email